Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

Q Ye, B Zou, YH Yeo, J Li, DQ Huang, Y Wu… - The lancet …, 2020 - thelancet.com
Background Although non-alcoholic fatty liver disease (NAFLD) is commonly associated
with obesity, it is increasingly being identified in non-obese individuals. We aimed to …

Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome

X Qu, R Donnelly - International journal of molecular sciences, 2020 - mdpi.com
Human sex hormone-binding globulin (SHBG) is a glycoprotein produced by the liver that
binds sex steroids with high affinity and specificity. Clinical observations and reports in the …

Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets?

V Francisco, MJ Sanz, JT Real, P Marques… - Biology, 2022 - mdpi.com
Simple Summary Non-alcoholic fatty liver disease (NAFLD) is an unmet medical need due to
its increasingly high incidence, severe clinical consequences, and the absence of feasible …

Dietary polyphenols and non-alcoholic fatty liver disease

L Abenavoli, T Larussa, A Corea, AC Procopio… - Nutrients, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD), which is emerging as a major public health issue
worldwide, is characterized by a wide spectrum of liver disorders, ranging from simple fat …

[HTML][HTML] Biomarkers for health functional foods in metabolic dysfunction-associated steatotic liver disorder (MASLD) prevention: an integrative analysis of network …

H Yuan, ES Jung, SW Chae, SJ Jung, JW Daily, S Park - Nutrients, 2024 - mdpi.com
Metabolic dysfunction-associated steatotic liver disorder (MASLD) is increasingly prevalent
globally, highlighting the need for preventive strategies and early interventions. This …

Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease

H Jang, Y Kim, DH Lee, SK Joo, BK Koo… - JAMA Internal …, 2024 - jamanetwork.com
Importance Several oral antidiabetic drug (OAD) classes can potentially improve patient
outcomes in nonalcoholic fatty liver disease (NAFLD) to varying degrees, but clinical data on …

Nonalcoholic fatty liver disease and staging of hepatic fibrosis

A Engin - Obesity and Lipotoxicity, 2024 - Springer
Nonalcoholic fatty liver disease (NAFLD) is in parallel with the obesity epidemic, and it is the
most common cause of liver diseases. The patients with severe insulin-resistant diabetes …

[HTML][HTML] Nonalcoholic fatty liver disease: an emerging modern-day risk factor for cardiovascular disease

G Hassen, A Singh, G Belete, N Jain, I De la Hoz… - Cureus, 2022 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD), also named metabolic dysfunction-associated fatty
liver disease (MAFLD), is a progressive disease spectrum encompassing simple steatosis …

Dietary supplementation of laminarin improves the reproductive performance of sows and the growth of suckling piglets

P Zhang, G Jiang, C Ma, Y Wang, E Yan, L He… - Journal of Animal …, 2023 - Springer
Background Maternal nutrition is essential in kee** a highly efficient production system in
the pig industry. Laminarin has been shown to improve antioxidant capacity, reduce the …

Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1/p-LKB-1/AMPK, HMGCR & …

MS Poornima, G Sindhu, A Billu, CR Sruthi… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance Dillenia indica L. is an edible plant from the Dilleniaceae
family present in the forest of India and other Asian countries. Different parts of this plant are …